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Inflammatory bowel disease (IBD) is a chronic pathological condition in which a variable part of the luminal layers of gastrointestinal tract becomes injured. This 
pathology includes Ulcerative Colitis and Crohn’s Disease. Its etiology is ignored, but it is known that involves the interaction of different factors, among which  
highlights the intestinal microbiota. The nature and mechanism of this interaction is already unknown. Since this pathology evolves to relapse, objectives of the 
treatment are to induce, and overalls to maintain, a state of clinical remission trying to reduce the frequency and duration of relapses. 
With that purpose, and relating  it  with the microbiota role on IBD development, probiotics have been focused as a possible treatment, and they are being tested in 
clinical trials.
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 Bioinformatic search of the appropriate scientific literature based on PubMed (NIH). Fields need to be limited at date and publication type (review, clinical trial).
Key words  Probiotic AND IBD, probiotic AND mechanism of action, gut microbiota
 Specific books of interest, to higlight: Prats, G. in Microbiol. y Parasitol. Médicas (Editorial Médica Panamericana S.A., 2012), Barcelona, Spain.
 For potential assessment of clinical evidence, 20 clinical trials have been chosen. 
Microbiota on health and disease Probiotics: mechanisms of action IBD & probiotics: toward the clinical 
Microbiota (normal~): heterogeneous group of 
microorganisms that colonize the mucous of the 
IBD probiotics management is very heterogenic in 
material, methods or objectives and results. 
Comparison of 20 clinical trials shown:
 To determine the role of the intestinal microbiota in a physiologic situation and in the development of IBD.  
 To determine and to value those probiotics that are being tested for the treatment and/or prevention of the relapses and/or remissions of IBD 
in human.  
 To relate the observed effects of this probiotics with their action mechanism.
Probiotic: alive and non-pathogenic 
microorganisms whose intake constitute some 
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whole organism. 
Among their functions there are included: 
 First defense VS pathogens
 Contributes to the maturation of immune 
system (IS) being a stimulus for it
Evidence: to expose an germ-free animal to 
microorganisms induces changes in their genetic 
expression (even at immune level)
Outcome:
Fig. 1 – IBD pathogenesis paradigm
IBD:
Microbiota 
imbalance
IS activation Inflammation
• ↑ frequency of dysbiotic microbiota
• Inflammatory process  causal 
relationship unknown
• ↑ poten9al pathogenic bacteria 
• ↓ protec9ve role bacteria
Fig. 2 – Probiotic’s mechanisms of action.
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Graphic 3. Proportion of studies with positive results achieved 
(green), unachieved (red) and with ambiguous results (blue) from a 
total of 20.
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Graphic 1. Variety of the usage of 
probiotics.
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Graphic 2. Evaluated parameters from the use of probiotics on IBD management. 
 Although the nature of the interaction among all the factors wrapped in IBD etiology is unknown, it has been shown the 
importance of microbiota alterations in their pathogenesis.
 Multiple probiotics are being tested in combination of different clinical situations of IBD, as long as 45% could produce a 
beneficial effect in some aspect of the pathology.
 It is not possible to achieve clear conclusions as for effectiveness or optimization of the treatment, as well as neither it is possible 
to determine the relationship between the observed effect and the mechanism of action of probiotics.
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benefit for the health.
